Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor (PBRM1-BD2 Kd=4.4 μM, PBRM1-BD2 IC50=0.16 μM; PBRM1-BD5 Kd=25 μM). PBRM1-BD2-IN-8 shows anti-cancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 172.00 | |
5 mg | In stock | $ 433.00 | |
10 mg | In stock | $ 628.00 | |
25 mg | In stock | $ 975.00 | |
50 mg | In stock | $ 1,290.00 | |
100 mg | In stock | $ 1,770.00 | |
500 mg | In stock | $ 3,550.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 425.00 |
Description | PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor (PBRM1-BD2 Kd=4.4 μM, PBRM1-BD2 IC50=0.16 μM; PBRM1-BD5 Kd=25 μM). PBRM1-BD2-IN-8 shows anti-cancer activity. |
In vitro | PBRM1-BD2-IN-8 (0-100 μM; 48 h) inhibits the growth of PBRM1-dependent prostate cancer cells[1]. |
Molecular Weight | 317.18 |
Formula | C15H13BrN2O |
CAS No. | 2819989-75-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (173.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PBRM1-BD2-IN-8 2819989-75-6 Chromatin/Epigenetic Epigenetic Reader Domain PBRM1BD2IN8 inhibitor inhibit